Medical Device News Magazine

Happy Bob App Integrates With Dexcom CGM to Provide a Playful Way to Engage With Real-Time Glucose Values and Improve Overall Self-Care

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Happy Bob App: Diabetes tech startup Harald AI today introduced a more expansive way for Dexcom Continuous Glucose Monitoring (CGM) System users to engage with their diabetes data through the popular Happy Bob App.

Through Dexcom’s real-time APIs, Happy Bob users can view their glucose values by quickly glancing at their Apple Watch or iPhone widget, create groups for support, collect stars and receive time-sensitive information and push notifications. Users can also see their historical data in the app for longer than 24 hours, access the expanded view, see insights on their desktop, and laugh at the in-app personalized messaging. Created by and for people with diabetes, Team Happy Bob has developed an app that alleviates the stress of daily management and glycemic control.

“Dexcom’s new Partner Web APIs opens the door for the future of connected devices. We are really excited to be one of their first collaborators and look forward to Dexcom users experiencing Happy Bob’s playful interface and ease of use. Diabetes exacts a huge mental toll and our app is designed to alleviate the data overload involved with daily care and glycemic control. Happy Bob is here to make your day better, and this partnership with Dexcom makes Happy Bob better able to do that,” says Jutta Haaramo, CEO at Harald AI.

Initially released in 2019, Happy Bob App quickly became popular with CGM users, who appreciated the personalized messages and gamification it offered. Embracing a lighter side to diabetes management was a game-changer in the digital data space and as a result, users were instantly more engaged and motivated to care for their health.

“Diabetes management is not a one-size-fits-all model, which is why we have always prioritized making our CGM data accessible to users in the platform of their choice,” said Jake Leach, executive vice president and chief technology officer at Dexcom. “We are excited to introduce Happy Bob as the latest partner to leverage our real-time APIs, which helps enable a more personalized and connected approach to continuous glucose monitoring.”

The Happy Bob App is available for download from the Apple App Store and Google Play Store for Dexcom CGM users in the U.S.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”